Scott W. Morrison serves as Executive at Global Blood Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Scott W. Morrison has executed 12 insider transactions totaling $145.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 15, 2025 involved exercising options for 1,334 shares valued at $0.
Scott W. Morrison currently holds 4,684 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott W. Morrison has been a net seller of GBT stock. They have purchased $0 and sold $145.0K worth of shares.
Scott W. Morrison's most recent insider trade was on Sep 15, 2025, when they sold 1,334 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 1,333 |
| $N/A |
| Discretionary |
| Jun 24, 2024 | TARS | $0 | Option Exercise | 3,350 | $N/A | Discretionary |
| Jun 18, 2024 | ZLAB | $0 | Award | 21,253 | $N/A | Discretionary |
| Sep 15, 2023 | TARS | $0 | Option Exercise | 1,333 | $N/A | Discretionary |
| Jun 29, 2023 | ZLAB | $500.0K | Award | 18,903 | $26.45 | Discretionary |
| Oct 5, 2022 | GBT | $0 | Disposition | 6,637 | $N/A | Discretionary |
| Jun 14, 2022 | GBT | $0 | Option Exercise | 3,600 | $N/A | Discretionary |
| Oct 18, 2021 | ZLAB | $0 | Award | 7,345 | $N/A | Discretionary |
| Sep 9, 2021 | GBT | $145.0K | Sale | 4,800 | $30.21 | Discretionary |
| Jun 17, 2021 | GBT | $0 | Option Exercise | 3,037 | $N/A | Discretionary |
| Jun 17, 2020 | GBT | $0 | Option Exercise | 4,800 | $N/A | Discretionary |